Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Kohlmann

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
JAMA Dermatology|July 10, 2014
Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasmJessica N Everett, Victoria M Raymond, Monica Dandapani, et al.
Journal of the National Cancer Institute|November 8, 2014
Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trialAnita Y Kinney, Karin M Butler, Marc D Schwartz, et al.
The Lancet. Oncology|August 10, 2016
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational studyAnita Villani, Ari Shore, Jonathan D Wasserman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-UpAnita Y Kinney, Laurie E Steffen, Barbara H Brumbach, et al.
Obstetrics and Gynecology|March 2, 2005
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndromeKaren H Lu, Mai Dinh, Wendy Kohlmann, et al.
Molecular Cancer Research : MCR|May 18, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providersKaren H Lu, Marie E Wood, Molly Daniels, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
PEC Innovation|December 19, 2022
Barriers to family history collection among Spanish-speaking primary care patients: a BRIDGE qualitative studyErica Liebermann, Peter Taber, Alexis S Vega, et al.
BMC Cancer|January 31, 2025
Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibilityJemar R Bather, Melody S Goodman, Adrian Harris, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
JAMA Dermatology|July 10, 2014
Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasmJessica N Everett, Victoria M Raymond, Monica Dandapani, et al.
Journal of the National Cancer Institute|November 8, 2014
Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trialAnita Y Kinney, Karin M Butler, Marc D Schwartz, et al.
The Lancet. Oncology|August 10, 2016
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational studyAnita Villani, Ari Shore, Jonathan D Wasserman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-UpAnita Y Kinney, Laurie E Steffen, Barbara H Brumbach, et al.
Obstetrics and Gynecology|March 2, 2005
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndromeKaren H Lu, Mai Dinh, Wendy Kohlmann, et al.
Molecular Cancer Research : MCR|May 18, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providersKaren H Lu, Marie E Wood, Molly Daniels, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
PEC Innovation|December 19, 2022
Barriers to family history collection among Spanish-speaking primary care patients: a BRIDGE qualitative studyErica Liebermann, Peter Taber, Alexis S Vega, et al.
BMC Cancer|January 31, 2025
Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibilityJemar R Bather, Melody S Goodman, Adrian Harris, et al.
Pageof 13